Patient Acceptance of Lactulose Varies Between Indian and American Cohorts: Implications for Comparing and Designing Global Hepatic Encephalopathy Trials

BACKGROUND: Lactulose is the first-line drug for hepatic encephalopathy (HE), but its acceptance widely differs between Western and Eastern studies. Patient preference for lactulose between different parts of the world has not been examined systematically. AIM: To define the preferences and reasons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Exp Hepatol
Main Authors: Rathi, Sahaj, Fagan, Andrew, Wade, James B., Chopra, Madhu, White, Melanie B., Ganapathy, Dinesh, Acharya, Chathur, Dhiman, Radha K., Bajaj, Jasmohan S.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992302/
https://ncbi.nlm.nih.gov/pubmed/29892171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2017.11.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados